HEADER TRANSPORT PROTEIN/INHIBITOR 30-MAR-15 4Z36 TITLE CRYSTAL STRUCTURE OF HUMAN LYSOPHOSPHATIDIC ACID RECEPTOR 1 IN COMPLEX TITLE 2 WITH ONO-3080573 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOPHOSPHATIDIC ACID RECEPTOR 1,SOLUBLE CYTOCHROME B562; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 2-232; UNP RESIDUES 23-64; UNP RESIDUES 78- COMPND 5 127; UNP RESIDUES 249-327; COMPND 6 SYNONYM: LPA-1,LYSOPHOSPHATIDIC ACID RECEPTOR EDG-2,CYTOCHROME B-562, COMPND 7 CYTOCHROME B-562,LPA-1,LYSOPHOSPHATIDIC ACID RECEPTOR EDG-2; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: LPAR1, EDG2, LPA1, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1711; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS HUMAN LYSOPHOSPHATIDIC ACID RECEPTOR 1 (LPA1), G-PROTEIN COUPLED KEYWDS 2 RECEPTOR (GPCR), MEMBRANE PROTEIN, ANTAGONIST, ENDOGENOUS LIGAND, KEYWDS 3 PSI-BIOLOGY, STRUCTURAL GENOMICS, GPCR NETWORK, LIPIDIC CUBIC PHASE KEYWDS 4 (LCP), NOVEL DISULFIDE BOND ENGINEERING, COMPOUND DESIGN, KEYWDS 5 POLYPHARMACOLOGY, LIPID RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR J.E.CHRENCIK,C.B.ROTH,M.TERAKADO,H.KURATA,R.OMI,Y.KIHARA, AUTHOR 2 D.WARSHAVIAK,S.NAKADE,G.ASMAR-ROVIRA,M.MILENI,H.MIZUNO,M.T.GRIFFITH, AUTHOR 3 C.RODGERS,G.W.HAN,J.VELASQUEZ,J.CHUN,R.C.STEVENS,M.A.HANSON,GPCR AUTHOR 4 NETWORK (GPCR) REVDAT 2 01-JUL-15 4Z36 1 JRNL REVDAT 1 03-JUN-15 4Z36 0 JRNL AUTH J.E.CHRENCIK,C.B.ROTH,M.TERAKADO,H.KURATA,R.OMI,Y.KIHARA, JRNL AUTH 2 D.WARSHAVIAK,S.NAKADE,G.ASMAR-ROVIRA,M.MILENI,H.MIZUNO, JRNL AUTH 3 M.T.GRIFFITH,C.RODGERS,G.W.HAN,J.VELASQUEZ,J.CHUN, JRNL AUTH 4 R.C.STEVENS,M.A.HANSON JRNL TITL CRYSTAL STRUCTURE OF ANTAGONIST BOUND HUMAN LYSOPHOSPHATIDIC JRNL TITL 2 ACID RECEPTOR 1. JRNL REF CELL V. 161 1633 2015 JRNL REFN ISSN 1097-4172 JRNL PMID 26091040 JRNL DOI 10.1016/J.CELL.2015.06.002 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 12660 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.273 REMARK 3 R VALUE (WORKING SET) : 0.272 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 625 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.11 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2593 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2572 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2476 REMARK 3 BIN R VALUE (WORKING SET) : 0.2562 REMARK 3 BIN FREE R VALUE : 0.2793 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.51 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 117 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3014 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 3 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 95.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.89450 REMARK 3 B22 (A**2) : -7.10170 REMARK 3 B33 (A**2) : -4.79280 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.684 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 4.569 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.426 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 2.352 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.429 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.885 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.848 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3141 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4267 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1445 ; 4.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 62 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 476 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3141 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 419 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3662 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.87 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.58 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.61 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -0.3047 -18.8188 30.2925 REMARK 3 T TENSOR REMARK 3 T11: -0.1899 T22: 0.1980 REMARK 3 T33: 0.1326 T12: -0.1437 REMARK 3 T13: -0.0055 T23: 0.0353 REMARK 3 L TENSOR REMARK 3 L11: 0.7166 L22: 0.8696 REMARK 3 L33: 0.3715 L12: -0.6523 REMARK 3 L13: 0.2160 L23: -0.7267 REMARK 3 S TENSOR REMARK 3 S11: -0.0088 S12: -0.0203 S13: -0.1395 REMARK 3 S21: -0.1020 S22: 0.1233 S23: -0.0956 REMARK 3 S31: -0.0382 S32: -0.0319 S33: -0.1145 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4Z36 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000208429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-NOV-13; 30-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 23-ID-D; 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033; 1.033 REMARK 200 MONOCHROMATOR : MIRRORS; MIRRORS REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD; MARMOSAIC REMARK 200 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12701 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.59000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE (PH 5.5), 34 - REMARK 280 38% (V/V) PEG400 AND 200 MM AMMONIUM ACETATE, LIPIDIC CUBIC REMARK 280 PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.17500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.98000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.96500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 76.98000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.17500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.96500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS HAVE INDICATED THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -17 REMARK 465 LYS A -16 REMARK 465 THR A -15 REMARK 465 ILE A -14 REMARK 465 ILE A -13 REMARK 465 ALA A -12 REMARK 465 LEU A -11 REMARK 465 SER A -10 REMARK 465 TYR A -9 REMARK 465 ILE A -8 REMARK 465 PHE A -7 REMARK 465 CYS A -6 REMARK 465 LEU A -5 REMARK 465 VAL A -4 REMARK 465 PHE A -3 REMARK 465 ALA A -2 REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 PRO A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ILE A 4 REMARK 465 SER A 5 REMARK 465 THR A 6 REMARK 465 SER A 7 REMARK 465 ILE A 8 REMARK 465 PRO A 9 REMARK 465 VAL A 10 REMARK 465 ILE A 11 REMARK 465 SER A 12 REMARK 465 GLN A 13 REMARK 465 PRO A 14 REMARK 465 GLN A 15 REMARK 465 PHE A 16 REMARK 465 THR A 17 REMARK 465 ALA A 18 REMARK 465 MET A 19 REMARK 465 ASN A 20 REMARK 465 GLU A 21 REMARK 465 PRO A 22 REMARK 465 GLY A 1049 REMARK 465 SER A 1050 REMARK 465 GLY A 1051 REMARK 465 GLY A 1052 REMARK 465 SER A 1053 REMARK 465 ASP A 1054 REMARK 465 SER A 1055 REMARK 465 PRO A 1056 REMARK 465 GLU A 1057 REMARK 465 ARG A 328 REMARK 465 PRO A 329 REMARK 465 LEU A 330 REMARK 465 GLU A 331 REMARK 465 VAL A 332 REMARK 465 LEU A 333 REMARK 465 PHE A 334 REMARK 465 GLN A 335 REMARK 465 GLY A 336 REMARK 465 PRO A 337 REMARK 465 HIS A 338 REMARK 465 HIS A 339 REMARK 465 HIS A 340 REMARK 465 HIS A 341 REMARK 465 HIS A 342 REMARK 465 HIS A 343 REMARK 465 HIS A 344 REMARK 465 HIS A 345 REMARK 465 HIS A 346 REMARK 465 HIS A 347 REMARK 465 ASP A 348 REMARK 465 TYR A 349 REMARK 465 LYS A 350 REMARK 465 ASP A 351 REMARK 465 ASP A 352 REMARK 465 ASP A 353 REMARK 465 ASP A 354 REMARK 465 LYS A 355 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 23 CG CD OE1 NE2 REMARK 470 ARG A 152 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1062 CG CD NE CZ NH1 NH2 REMARK 470 LEU A1106 CG CD1 CD2 REMARK 470 GLN A 286 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 24 95.78 -68.95 REMARK 500 MET A 153 -59.83 64.90 REMARK 500 ASP A 191 52.06 -143.41 REMARK 500 ASN A 194 38.69 -99.26 REMARK 500 GLN A 286 0.97 84.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 1WV A 2001 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ON3 A 2000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1WV A 2001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: GPCR-235 RELATED DB: TARGETTRACK REMARK 900 RELATED ID: 4Z34 RELATED DB: PDB REMARK 900 RELATED ID: 4Z35 RELATED DB: PDB DBREF 4Z36 A 2 232 UNP Q92633 LPAR1_HUMAN 2 232 DBREF 4Z36 A 1001 1042 UNP P0ABE7 C562_ECOLX 23 64 DBREF 4Z36 A 1056 1105 UNP P0ABE7 C562_ECOLX 78 127 DBREF 4Z36 A 248 326 UNP Q92633 LPAR1_HUMAN 249 327 SEQADV 4Z36 MET A -17 UNP Q92633 INITIATING METHIONINE SEQADV 4Z36 LYS A -16 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 THR A -15 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ILE A -14 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ILE A -13 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ALA A -12 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LEU A -11 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 SER A -10 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 TYR A -9 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ILE A -8 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PHE A -7 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 CYS A -6 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LEU A -5 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 VAL A -4 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PHE A -3 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ALA A -2 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 GLY A -1 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ALA A 0 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PRO A 1 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 CYS A 204 UNP Q92633 ASP 204 ENGINEERED MUTATION SEQADV 4Z36 TRP A 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 4Z36 GLY A 1043 UNP P0ABE7 LINKER SEQADV 4Z36 GLY A 1049 UNP P0ABE7 LINKER SEQADV 4Z36 SER A 1050 UNP P0ABE7 LINKER SEQADV 4Z36 GLY A 1051 UNP P0ABE7 LINKER SEQADV 4Z36 GLY A 1052 UNP P0ABE7 LINKER SEQADV 4Z36 SER A 1053 UNP P0ABE7 LINKER SEQADV 4Z36 ASP A 1054 UNP P0ABE7 LINKER SEQADV 4Z36 SER A 1055 UNP P0ABE7 LINKER SEQADV 4Z36 ILE A 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 4Z36 LEU A 1106 UNP P0ABE7 LINKER SEQADV 4Z36 CYS A 282 UNP Q92633 VAL 283 CONFLICT SEQADV 4Z36 GLY A 327 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ARG A 328 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PRO A 329 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LEU A 330 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 GLU A 331 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 VAL A 332 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LEU A 333 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PHE A 334 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 GLN A 335 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 GLY A 336 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PRO A 337 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 338 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 339 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 340 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 341 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 342 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 343 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 344 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 345 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 346 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 347 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 348 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 TYR A 349 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LYS A 350 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 351 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 352 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 353 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 354 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LYS A 355 UNP Q92633 EXPRESSION TAG SEQRES 1 A 459 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 A 459 VAL PHE ALA GLY ALA PRO ALA ALA ILE SER THR SER ILE SEQRES 3 A 459 PRO VAL ILE SER GLN PRO GLN PHE THR ALA MET ASN GLU SEQRES 4 A 459 PRO GLN CYS PHE TYR ASN GLU SER ILE ALA PHE PHE TYR SEQRES 5 A 459 ASN ARG SER GLY LYS HIS LEU ALA THR GLU TRP ASN THR SEQRES 6 A 459 VAL SER LYS LEU VAL MET GLY LEU GLY ILE THR VAL CYS SEQRES 7 A 459 ILE PHE ILE MET LEU ALA ASN LEU LEU VAL MET VAL ALA SEQRES 8 A 459 ILE TYR VAL ASN ARG ARG PHE HIS PHE PRO ILE TYR TYR SEQRES 9 A 459 LEU MET ALA ASN LEU ALA ALA ALA ASP PHE PHE ALA GLY SEQRES 10 A 459 LEU ALA TYR PHE TYR LEU MET PHE ASN THR GLY PRO ASN SEQRES 11 A 459 THR ARG ARG LEU THR VAL SER THR TRP LEU LEU ARG GLN SEQRES 12 A 459 GLY LEU ILE ASP THR SER LEU THR ALA SER VAL ALA ASN SEQRES 13 A 459 LEU LEU ALA ILE ALA ILE GLU ARG HIS ILE THR VAL PHE SEQRES 14 A 459 ARG MET GLN LEU HIS THR ARG MET SER ASN ARG ARG VAL SEQRES 15 A 459 VAL VAL VAL ILE VAL VAL ILE TRP THR MET ALA ILE VAL SEQRES 16 A 459 MET GLY ALA ILE PRO SER VAL GLY TRP ASN CYS ILE CYS SEQRES 17 A 459 ASP ILE GLU ASN CYS SER ASN MET ALA PRO LEU TYR SER SEQRES 18 A 459 CYS SER TYR LEU VAL PHE TRP ALA ILE PHE ASN LEU VAL SEQRES 19 A 459 THR PHE VAL VAL MET VAL VAL LEU TYR ALA HIS ILE PHE SEQRES 20 A 459 GLY TYR VAL ALA ASP LEU GLU ASP ASN TRP GLU THR LEU SEQRES 21 A 459 ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA SEQRES 22 A 459 ALA GLN VAL LYS ASP ALA LEU THR LYS MET ARG ALA ALA SEQRES 23 A 459 ALA LEU ASP ALA GLN LYS GLY GLY SER GLY GLY SER ASP SEQRES 24 A 459 SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE ASP ILE SEQRES 25 A 459 LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU ALA ASN SEQRES 26 A 459 GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA GLU GLN SEQRES 27 A 459 LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS TYR LEU SEQRES 28 A 459 ARG ASN ARG ASP THR MET MET SER LEU LEU LYS THR VAL SEQRES 29 A 459 VAL ILE VAL LEU GLY ALA PHE ILE ILE CYS TRP THR PRO SEQRES 30 A 459 GLY LEU VAL LEU LEU LEU LEU ASP CYS CYS CYS PRO GLN SEQRES 31 A 459 CYS ASP VAL LEU ALA TYR GLU LYS PHE PHE LEU LEU LEU SEQRES 32 A 459 ALA GLU PHE ASN SER ALA MET ASN PRO ILE ILE TYR SER SEQRES 33 A 459 TYR ARG ASP LYS GLU MET SER ALA THR PHE ARG GLN ILE SEQRES 34 A 459 LEU GLY ARG PRO LEU GLU VAL LEU PHE GLN GLY PRO HIS SEQRES 35 A 459 HIS HIS HIS HIS HIS HIS HIS HIS HIS ASP TYR LYS ASP SEQRES 36 A 459 ASP ASP ASP LYS HET ON3 A2000 38 HET 1WV A2001 18 HETNAM ON3 1-(4-{[(2S,3R)-2-(2,3-DIHYDRO-1H-INDEN-2-YLOXY)-3-(3,5- HETNAM 2 ON3 DIMETHOXY-4-METHYLPHENYL)-3-HYDROXYPROPYL]OXY}PHENYL) HETNAM 3 ON3 CYCLOPROPANECARBOXYLIC ACID HETNAM 1WV (2S)-2,3-DIHYDROXYPROPYL (7Z)-TETRADEC-7-ENOATE HETSYN ON3 ONO-3080573 FORMUL 2 ON3 C31 H34 O7 FORMUL 3 1WV C17 H32 O4 FORMUL 4 HOH *3(H2 O) HELIX 1 AA1 SER A 29 SER A 37 1 9 HELIX 2 AA2 ASN A 46 ASN A 77 1 32 HELIX 3 AA3 ARG A 78 HIS A 81 5 4 HELIX 4 AA4 PHE A 82 PHE A 107 1 26 HELIX 5 AA5 ASN A 108 ARG A 114 5 7 HELIX 6 AA6 THR A 117 ARG A 152 1 36 HELIX 7 AA7 THR A 157 GLY A 179 1 23 HELIX 8 AA8 ALA A 180 VAL A 184 5 5 HELIX 9 AA9 ASP A 191 CYS A 195 5 5 HELIX 10 AB1 SER A 203 LYS A 1019 1 49 HELIX 11 AB2 ASN A 1022 GLN A 1041 1 20 HELIX 12 AB3 PHE A 1061 GLY A 1082 1 22 HELIX 13 AB4 LYS A 1083 ASN A 1099 1 17 HELIX 14 AB5 ASN A 249 CYS A 284 1 36 HELIX 15 AB6 GLU A 293 ASP A 315 1 23 HELIX 16 AB7 ASP A 315 GLY A 327 1 13 SSBOND 1 CYS A 24 CYS A 190 1555 1555 2.04 SSBOND 2 CYS A 188 CYS A 195 1555 1555 2.04 SSBOND 3 CYS A 204 CYS A 282 1555 1555 2.04 SSBOND 4 CYS A 284 CYS A 287 1555 1555 2.04 SITE 1 AC1 13 VAL A 52 THR A 109 GLN A 125 ILE A 128 SITE 2 AC1 13 ASP A 129 TRP A 210 TRP A 271 GLY A 274 SITE 3 AC1 13 LEU A 278 GLU A 293 LYS A 294 PHE A 296 SITE 4 AC1 13 LEU A 297 SITE 1 AC2 5 LEU A 51 LEU A 122 THR A 130 GLY A 179 SITE 2 AC2 5 SER A 183 CRYST1 34.350 111.930 153.960 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029112 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008934 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006495 0.00000